VALENCIA, Calif., April 11, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) will host
an analyst call for the investment community to learn about the company's general commercialization strategy in the US for
Afrezza® (insulin human) Inhalation Powder. MannKind has recently assumed responsibility for the worldwide development
and commercialization of Afrezza from Sanofi and will begin to distribute Afrezza in the third quarter. Until that time, Sanofi
will continue to distribute Afrezza from its existing inventory of product.
To participate in the live call by telephone, please dial (888) 224-7957 or (303) 223-4394 and use the participant passcode:
Time slots have been updated for the May symposium.
Dr. Missling will be speaking from 15.40-16.10, a hefty 30 minutes. That should be more than enough time to go over lots and lots of data!
Imo. another weak attempt by colluding shorts, but not working because the longs are strong here and know how they twist information. Shorts are scared. Remember bad stocks don't need to be bashed only good ones!
Same online gaming as MGT.
The name change itself will have investors flocking to stock. I will not short this one here. Maybe at $30.+
Frederick H. Earnest, President and Chief Executive Officer, commented, "We continue to believe that our balance sheet will fund our currently planned activities into 2018.
"We are encouraged by the apparent renewed interest in the gold sector and the significant leverage that Vista stock has displayed relative to gold price changes.
Great for all oncology drugs !
Our working capital at March 31, 2016 totaled approximately $14.0 million, including cash and short-term investments (comprised of government securities) of approximately $12.0 million. The Company has no debt.
This drug delivery system makes current oncology drugs more efficient. Kills the bad cells not the good. CELG would be my guess.
AF should stop. This will be another of his failures. 2 orphan drug designations now. FDA on top of this company.
any idea why?